Effects of atorvastatin on the inflammation regulation and elimination of subdural hematoma in rats

Journal of the Neurological Sciences

Volumn 341, Issue 1-2, 2014, Pages 88-96

  Li, Tuo ^a,b,c   Wang, Dong ^a,b,c   Tian, Ye ^a,b,c   Yu, Huijie ^a,b,c   Wang, Yi ^a,b,c   Quan, Wei ^a,b,c   Cui, Weiyun ^b   Zhou, Lei ^b   Chen, Jieli ^d   Jiang, Rongcai ^a,b,c   Zhang, Jianning ^a,b,c  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b Tian Jin Normal University   (China)

^c BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^d HENRY FORD HOSPITAL   (United States)

Author keywords

Angiogenesis; Atorvastatin; Cytokine; ELISA; Inflammation; Subdural hematoma

Indexed keywords

ATORVASTATIN; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; CYTOKINE; HEPTANOIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; PYRROLE DERIVATIVE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; GENE EXPRESSION; MALE; MICROSCOPY; NEUTROPHIL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; SUBDURAL HEMATOMA; ANALYSIS OF VARIANCE; ANIMAL; BLOOD CELL COUNT; BRAIN; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; HEMATOMA, SUBDURAL; IMAGE PROCESSING; INFLAMMATION; METABOLISM; NEUROLOGIC EXAMINATION; PATHOLOGY; TIME; WISTAR RAT;

ANALYSIS OF VARIANCE; ANIMALS; BLOOD CELL COUNT; BRAIN; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEMATOMA, SUBDURAL; HEPTANOIC ACIDS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IMAGE PROCESSING, COMPUTER-ASSISTED; INFLAMMATION; LIPIDS; MAGNETIC RESONANCE IMAGING; MALE; NEUROLOGIC EXAMINATION; PYRROLES; RATS; RATS, WISTAR; TIME FACTORS;

EID: 84901235119     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2014.04.009     Document Type: Article

References (49)

1. M.R. Bullock, R. Chesnut, J. Ghajar, D. Gordon, R. Hartl, and D.W. Newell et al. Surgical management of acute subdural hematomas Neurosurgery 58 2006 S16 S24 [discussion Si-iv]
2. J.M. Seelig, D.P. Becker, J.D. Miller, R.P. Greenberg, J.D. Ward, and S.C. Choi Traumatic acute subdural hematoma: major mortality reduction in comatose patients treated within four hours N Engl J Med 304 1981 1511 1518
3. J.E. Wilberger, M. Harris, and D.L. Diamond Acute subdural hematoma: morbidity, mortality, and operative timing J Neurosurg 74 1991 212 218
4. R. Weigel, P. Schmiedek, and J.K. Krauss Outcome of contemporary surgery for chronic subdural haematoma: evidence based review J Neurol Neurosurg Psychiatry 74 2003 937 943
5. W. Schachenmayr, and R.L. Friede The origin of subdural neomembranes. I. Fine structure of the dura-arachnoid interface in man Am J Pathol 92 1978 53 68
6. M. Moskala, I. Goscinski, J. Kaluza, J. Polak, M. Krupa, and D. Adamek et al. Morphological aspects of the traumatic chronic subdural hematoma capsule: SEM studies Microsc Microanal 13 2007 211 219
7. T. Yamashima, and S. Yamamoto The origin of inner membranes in chronic subdural hematomas Acta Neuropathol 67 1985 219 225
8. M. Suzuki, S. Endo, K. Inada, A. Kudo, A. Kitakami, and K. Kuroda et al. Inflammatory cytokines locally elevated in chronic subdural haematoma Acta Neurochir 140 1998 51 55
9. P.D. Delgado-Lopez, V. Martin-Velasco, J.M. Castilla-Diez, A. Rodriguez-Salazar, A.M. Galacho-Harriero, and O. Fernandez-Arconada Dexamethasone treatment in chronic subdural haematoma Neurocirugia (Astur) 20 2009 346 359
10. J. Vardy, K.S. Chiew, J. Galica, G.R. Pond, and I.F. Tannock Side effects associated with the use of dexamethasone for prophylaxis of delayed emesis after moderately emetogenic chemotherapy Br J Cancer 94 2006 1011 1015
11. S. Dimmeler, A. Aicher, M. Vasa, C. Mildner-Rihm, K. Adler, and M. Tiemann et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway J Clin Invest 108 2001 391 397
12. M.K. Jain, and P.M. Ridker Anti-inflammatory effects of statins: clinical evidence and basic mechanisms Nat Rev Drug Discov 4 2005 977 987
13. L. Verschuren, R. Kleemann, E.H. Offerman, A.J. Szalai, S.J. Emeis, and H.M. Princen et al. Effect of low dose atorvastatin versus diet-induced cholesterol lowering on atherosclerotic lesion progression and inflammation in apolipoprotein E*3-Leiden transgenic mice Arterioscler Thromb Vasc Biol 25 2005 161 167
14. R. Kleemann, H.M. Princen, J.J. Emeis, J.W. Jukema, R.D. Fontijn, and A.J. Horrevoets et al. Rosuvastatin reduces atherosclerosis development beyond and independent of its plasma cholesterol-lowering effect in APOE*3-Leiden transgenic mice: evidence for antiinflammatory effects of rosuvastatin Circulation 108 2003 1368 1374
15. D. Wang, R. Jiang, L. Liu, J.F. Dong, and J.N. Zhang Membrane neovascularization and drainage of subdural hematoma in a rat model J Neurotrauma 27 2010 1489 1498
16. R.B. Hessler, H. Kfoury, J. Al-Watban, and M. Hassounah Angiomatous pleomorphic xanthoastrocytoma as a component of ganglioglioma Ann Saudi Med 19 1999 48 51
17. E.L. Labadie, and D. Glover Chronic subdural hematoma: concepts of physiopathogenesis. A review Can J Neurol Sci 1 1974 222 225
18. S. Watanabe, H. Shimada, and S. Ishii Production of clinical form of chronic subdural hematoma in experimental animals J Neurosurg 37 1972 552 561
19. H. Ito, K. Saito, S. Yamamoto, and T. Hasegawa Tissue-type plasminogen activator in the chronic subdural hematoma Surg Neurol 30 1988 175 179
20. Y. Kawakami, M. Chikama, T. Tamiya, and Y. Shimamura Coagulation and fibrinolysis in chronic subdural hematoma Neurosurgery 25 1989 25 29
21. K. Saito, H. Ito, T. Hasegawa, and S. Yamamoto Plasmin-alpha 2-plasmin inhibitor complex and alpha 2-plasmin inhibitor in chronic subdural hematoma J Neurosurg 70 1989 68 72
22. H. Katano, K. Kamiya, M. Mase, M. Tanikawa, and K. Yamada Tissue plasminogen activator in chronic subdural hematomas as a predictor of recurrence J Neurosurg 104 2006 79 84
23. T. Shono, T. Inamura, T. Morioka, K. Matsumoto, S.O. Suzuki, and K. Ikezaki et al. Vascular endothelial growth factor in chronic subdural haematomas J Clin Neurosci 8 2001 411 415
24. A. Hohenstein, R. Erber, L. Schilling, and R. Weigel Increased mRNA expression of VEGF within the hematoma and imbalance of angiopoietin-1 and -2 mRNA within the neomembranes of chronic subdural hematoma J Neurotrauma 22 2005 518 528
25. N. Nanko, M. Tanikawa, M. Mase, M. Fujita, H. Tateyama, and T. Miyati et al. Involvement of hypoxia-inducible factor-1alpha and vascular endothelial growth factor in the mechanism of development of chronic subdural hematoma Neurol Med Chir 49 2009 379 385
26. H.J. Hong, Y.J. Kim, H.J. Yi, Y. Ko, S.J. Oh, and J.M. Kim Role of angiogenic growth factors and inflammatory cytokine on recurrence of chronic subdural hematoma Surg Neurol 71 2009 161 165 [discussion 5-6]
27. T. Wada, K. Kuroda, Y. Yoshida, K. Ogasawara, A. Ogawa, and S. Endo Local elevation of the anti-inflammatory interleukin-10 in the pathogenesis of chronic subdural hematoma Neurosurg Rev 29 2006 242 245
28. L.E. Glover, and S.P. Colgan Hypoxia and metabolic factors that influence inflammatory bowel disease pathogenesis Gastroenterology 140 2011 1748 1755
29. B. Wang, L. Sun, Y. Tian, Z. Li, H. Wei, and D. Wang et al. Effects of atorvastatin in the regulation of circulating EPCs and angiogenesis in traumatic brain injury in rats J Neurol Sci 319 2012 117 123
30. F.A. Araujo, M.A. Rocha, J.B. Mendes, and S.P. Andrade Atorvastatin inhibits inflammatory angiogenesis in mice through down regulation of VEGF, TNF-alpha and TGF-beta1 Biomed Pharmacother 64 2010 29 34
31. Y. Wang, H. Chang, J. Zou, X. Jin, and Z. Qi The effect of atorvastatin on mRNA levels of inflammatory genes expression in human peripheral blood lymphocytes by DNA microarray Biomed Pharmacother 65 2011 118 122
32. K.J. Tracey The inflammatory reflex Nature 420 2002 853 859
33. K. Dvorak, and B. Dvorak Role of interleukin-6 in Barrett's esophagus pathogenesis World J Gastroenterol 19 2013 2307 2312
34. S.M. Hurst, T.S. Wilkinson, R.M. McLoughlin, S. Jones, S. Horiuchi, and N. Yamamoto et al. Il-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation Immunity 14 2001 705 714
35. M. Feldmann, F.M. Brennan, and R.N. Maini Role of cytokines in rheumatoid arthritis Annu Rev Immunol 14 1996 397 440
36. R.M. Seymour, and B. Henderson Pro-inflammatory-anti-inflammatory cytokine dynamics mediated by cytokine-receptor dynamics in monocytes IMA J Math Appl Med Biol 18 2001 159 192
37. I. Petrache, A. Birukova, S.I. Ramirez, J.G. Garcia, and A.D. Verin The role of the microtubules in tumor necrosis factor-alpha-induced endothelial cell permeability Am J Respir Cell Mol Biol 28 2003 574 581
38. A.K. Kiemer, N.C. Weber, R. Furst, N. Bildner, S. Kulhanek-Heinze, and A.M. Vollmar Inhibition of p38 MAPK activation via induction of MKP-1: atrial natriuretic peptide reduces TNF-alpha-induced actin polymerization and endothelial permeability Circ Res 90 2002 874 881
39. J. Friedl, M. Puhlmann, D.L. Bartlett, S.K. Libutti, E.N. Turner, and M.F. Gnant et al. Induction of permeability across endothelial cell monolayers by tumor necrosis factor (TNF) occurs via a tissue factor-dependent mechanism: relationship between the procoagulant and permeability effects of TNF Blood 100 2002 1334 1339
40. S.N. Umapathy, E. Kaczmarek, N. Fatteh, N. Burns, R. Lucas, and K.R. Stenmark et al. Adenosine A1 receptors promote vasa vasorum endothelial cell barrier integrity via Gi and Akt-dependent actin cytoskeleton remodeling PLoS One 8 2013 e59733
41. N. Maruo, I. Morita, M. Shirao, and S. Murota IL-6 increases endothelial permeability in vitro Endocrinology 131 1992 710 714
42. D. Glover, and E.L. Labadie Physiopathogenesis of subdural hematomas. Part 2: Inhibition of growth of experimental hematomas with dexamethasone J Neurosurg 45 1976 393 397
43. H. Ito, S. Yamamoto, T. Komai, and H. Mizukoshi Role of local hyperfibrinolysis in the etiology of chronic subdural hematoma J Neurosurg 45 1976 26 31
44. E.L. Labadie, and D. Glover Physiopathogenesis of subdural hematomas. Part 1: Histological and biochemical comparisons of subcutaneous hematoma in rats with subdural hematoma in man J Neurosurg 45 1976 382 392
45. S. Sato, and J. Suzuki Ultrastructural observations of the capsule of chronic subdural hematoma in various clinical stages J Neurosurg 43 1975 569 578
46. T. Yamashima, S. Yamamoto, and R.L. Friede The role of endothelial gap junctions in the enlargement of chronic subdural hematomas J Neurosurg 59 1983 298 303
47. M. Matsumura, N. Fukuda, N. Kobayashi, H. Umezawa, A. Takasaka, and T. Matsumoto et al. Effects of atorvastatin on angiogenesis in hindlimb ischemia and endothelial progenitor cell formation in rats J Atheroscler Thromb 16 2009 319 326
48. S. Tsigkos, M. Koutsilieris, and A. Papapetropoulos Angiopoietins in angiogenesis and beyond Expert Opin Investig Drugs 12 2003 933 941
49. G.D. Yancopoulos, S. Davis, N.W. Gale, J.S. Rudge, S.J. Wiegand, and J. Holash Vascular-specific growth factors and blood vessel formation Nature 407 2000 242 248